Role of alternative splicing in cancer progression
- 13 March 2026
- journal article
- review article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (3) , 1209-1225
Abstract
No abstract availableKeywords
This publication has 158 references indexed in Scilit:
- Comprehensive Overview of Computational Tools for Alternative Splicing AnalysisWIREs RNA, 2025
- Short‐chain acyl post‐translational modifications in cancers: Mechanisms, roles, and therapeutic implicationsCancer Communications, 2025
- Natural Products and lncRNAs in Renal Cell Carcinoma: Emerging Therapeutic ApproachesThe Journal of Gene Medicine, 2025
- Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in CancerCancer Medicine, 2025
- PD-L1 importance in malignancies comprehensive insights into the role of PD-L1 in malignancies: from molecular mechanisms to therapeutic opportunitiesClinical and Experimental Medicine, 2025
- Advances and clinical applications of immune checkpoint inhibitors in hematological malignanciesCancer Communications, 2024
- Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapiesClinical and Translational Medicine, 2024
- Long Non-coding RNAs in Cancer2024
- Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD‐L1 in Cancer TherapyAdvanced Science, 2023
- Regulation of alternative splicing: Functional interplay with epigenetic modifications and its implication to cancerWIREs RNA, 2023